Naturally nonanemic dialysis patients: Who are they?
- 4 May 2016
- journal article
- Published by Wiley in Hemodialysis International
- Vol. 20 (4) , 522-529
Abstract
Introduction Not only anemia, but also erythropoiesis stimulating agent (ESA)s for treating anemia may adversely affect prognosis of chronic hemodialysis patients. Various features of naturally (with no ESA usage) nonanemic patients may be useful for defining several factors in the pathogenesis of anemia.Methods Data, retrieved from the European Clinical Database (EuCliD)‐Turkey on naturally nonanemic prevalent chronic hemodialysis patients (n: 201) were compared with their anemic (those who required ESA treatment) counterparts (n: 3948).Findings Mean hemoglobin values were 13.5 ± 0.8 and 11.5 ± 0.9 g/dL in nonanemic and anemic patients, respectively (P < 0.001). Nonanemia status was associated with younger age, male gender, longer dialysis vintage, nondiabetic status, more frequent hepatitis‐C virus seropositivity and more frequent arteriovenous fistula usage. Serum ferritin and CRP levels and urea reduction ratio were higher in ESA‐requiring patients. One (99%) and two (95.3%) years survival rates of the “naturally nonanemic” patients were superior as compared to anemics (91.0% and 82.6%, respectively), (P < 0.001).Discussion “Naturally nonanemic” status is associated with better survival in prevalent chronic hemodialysis patients; underlying mechanisms in this favorable outcome should be investigated by randomized controlled trials including large number of patients.Keywords
This publication has 29 references indexed in Scilit:
- Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort studyBMC Nephrology, 2012
- Chapter 8 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2010: National and Centre-Specific AnalysesNephron Clinical Practice, 2012
- Naturally Occurring Higher Hemoglobin Concentration Does Not Increase Mortality among Hemodialysis PatientsJournal of the American Society of Nephrology, 2011
- Facility-Level Interpatient Hemoglobin Variability in Hemodialysis Centers Participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations With Mortality, Patient Characteristics, and Facility PracticesAmerican Journal of Kidney Diseases, 2011
- Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in HemodialysisAmerican Journal of Kidney Diseases, 2008
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesKidney International, 2008
- Hemoglobin Variability and Mortality in ESRDJournal of the American Society of Nephrology, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Does hepatitis C virus infection increase hematocrit and hemoglobin levels in hemodialyzed patients?Clinical Nephrology, 2003
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993